SCHEMBL30890404

SCHEMBL30890404

CCCCOC(=O)N1CC2(C[C@H]1C(=O)O)Oc1ccccc1NC2=O

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ TSHR P16473 2/20 0.34
▸ BCHE P06276 1/20 0.34
▸ ECE1 P42892 1/20 0.33
▸ L3MBTL1 Q9Y468 3/20 0.33
▸ ACE P12821 2/20 0.33
▸ ACE2 Q9BYF1 2/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ PKM P14618 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890444 1.00 POLB (0.36) POLBHSD17B10MAPTTSHRBCHE
SCHEMBL30890412 0.92 HSD17B10 (0.36) POLBHSD17B10MAPTTSHRBCHE
SCHEMBL30890576 0.86 OTUD7B (0.41) MAPTTSHRBCHEECE1L3MBTL1
SCHEMBL30890749 0.82 NR1H2 (0.42) POLBHSD17B10MAPTMAPK1
SCHEMBL27245125 0.81 MAPT (0.38) POLBHSD17B10MAPTL3MBTL1MEN1
SCHEMBL30890571 0.79 MAPT (0.34) MAPTL3MBTL1MEN1KMT2A
SCHEMBL30890780 0.79 MAOB (0.34) MAPTTSHRMEN1KMT2AKDM4E
SCHEMBL30890741 0.79 RECQL (0.34) POLBMAPTTSHRTDP1MAPK1
SCHEMBL30890510 0.78 OTUD7B (0.40) POLBHSD17B10TSHRBCHEECE1
SCHEMBL30890474 0.78 TSHR (0.32) TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback